JURA Bio, Inc.

Website

Advertisement

100 William T Morrissey Blvd Ste 3
Dorchester, MA 02125
https://www.jurabio.com

JURA Bio, Inc. is a cutting-edge biotechnology company based in Dorchester, MA, dedicated to revolutionizing genomic medicines by expanding the scope of immune therapies. Through their innovative ML-guided discovery development platform, they leverage synthetic biology and probabilistic machine learning to design, build, and test the next generation of genomic medicines on a large scale.

With a strong commitment to advancing healthcare, JURA Bio, Inc. proudly collaborates with research partners and supports ongoing efforts to address understudied autoimmune diseases, such as ProjectClio.Org. Their transformative approach is poised to reshape the field of medicine and improve patient outcomes.

Generated from the website

Also at this address

Own this business?
See a problem?

You might also like

Specialized dental practitioners, Real estate managers

Boston Public Health Commission

The Boston Public Health Commission (BPHC) serves as the local health department for the City of Boston, focusing on a wide spectrum of services, programs, and advocacy aimed at promoting health equity across the community. Its initiatives reflect a commitment to addressing diverse health needs and improving public health for all residents. Located at several facilities throughout Boston, the BPHC prioritizes accessibility through various public transportation options, ensuring that individuals can easily reach its resources. The Commission is equipped to handle a range of public health concerns and works diligently to maintain the privacy and confidentiality of its patients. Generated from the website
Services, nec, nec, Business services, nec, nec, Drugs and drug proprietaries

Matrivax Research & Development Corporation

Matrivax Research & Development Corporation, based in Boston, MA, is at the forefront of vaccine innovation, dedicated to developing life-saving vaccines for populations in need worldwide. Their efforts focus on a next-generation pneumococcal vaccine and a novel C. difficile vaccine, both addressing critical global health threats. The pneumococcal vaccine aims to significantly reduce the impact of Streptococcus pneumoniae infections, which claim over one million lives annually. Meanwhile, the C. difficile vaccine targets the bacteria and toxins responsible for a substantial number of infections in the U.S., presenting a promising solution to an urgent public health crisis. Generated from the website
Drugs acting on the respiratory system

Jnana Therapeutics

Jnana Therapeutics is a Boston-based biotechnology company specializing in the development of innovative therapies. With a focus on their RAPID platform, they aim to revolutionize the treatment of various diseases by targeting cellular transport mechanisms. Driven by a dedicated team and cutting-edge research, Jnana Therapeutics is committed to advancing their programs and making a significant impact in the field of medicine through their novel approaches.Generated from the website
United States›Massachusetts›Dorchester›JURA Bio, Inc.

Partial Data by Infogroup (c) 2024. All rights reserved.

Advertisement